Navigation Links
Excalibur International Marine (49% Owned by EFT BioTech Holdings) Completes Inaugural Passenger Crossing of Taiwan Strait
Date:6/30/2009

CITY OF INDUSTRY, Calif. and HONG KONG, June 30 /PRNewswire-FirstCall/ -- EFT BioTech Holdings, Inc. (Pink Sheets: EFTB), announced today that Excalibur's Ocean LaLa has successfully completed its inaugural Taiwan Strait passenger voyage which has been highlighted in multiple news articles and internet news sites, including the Taiwan Sun, and the Qatar Tribune. The article states:

"A Taiwan company launched a cruise service with China on Sunday, making it the first such cross-strait service in 60 years.

"With a band playing and dragon dance performing on shore, the 2,292-tonne Ocean LaLa set sail from the Taichung Harbour for Xiamen, China, carrying 179 passengers and 23 crew.

"The voyage across the Taiwan Strait takes only four-and-a-half-hours, but it took Taiwan and China 60 years to ease tension and for Taipei to agree to lift the ban on sea links with the mainland."

The Excalibur International Marine Corp, operator of the cruise service, said that in the initial stage, the Taichung-Xianmen cruise is an irregular service chartered by travel agencies.

"Eventually it will become a regular cruise service going not only to Xiamen, but also to other Chinese ports like Fuzhou and Shanghai," said Han Chih-yang, Excalibur's deputy.

"We are full of confidence for the future of cross-strait tourism, so we are seeking to buy two larger ships for launching regular cross-strait service," he said.

Jack Qin, the President and CEO of EFT BioTech Holdings, stated, "We are excited to be recognized by the world press and this article shows that people are truly interested in this much needed passenger and cargo service."

About EFT BioTech Holdings, Inc.

EFT BioTech Holdings, Inc. is a Nevada holding company which conducts its business through its wholly-owned subsidiary, EFT Bio
'/>"/>

SOURCE EFT BioTech Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Excalibur - Transforming Biotech Deals can Still be Achieved
2. Excalibur Celebrates PIramed Sale With Substantial Cash Return to Investors
3. Galichia Heart Hospital Partners with Mobile Surgery International to Develop Wichita-based Center of Excellence with Global Convenience(TM)
4. International Products Corp.s Lab Offers Filter Membrane Compatibility and Studies
5. Cord Blood America Continues International Expansion
6. PAREXEL International to Present at the Wachovia Equity Conference
7. BioEnergy International, LLC Announces Formation of Myriant Technologies LLC
8. Biostar Pharmaceuticals, Inc. Retains HC International, Inc. to Implement Investor Relations Program
9. NeoStem, Inc. Appoints Financial Expert with Broad International Experience to the Board of Directors and to Serve as Chairman of the Companys Audit Committee
10. Yongye Biotechnology International Receives License to Manufacture Products
11. Cynvec to Present at the 11th Annual Shanghai International Forum on Biotechnology and Pharmaceutical Industry

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)... The agenda for Arrowhead’s 2010 Personalize...o take place on February 22-24, 2010 in Philadelph...ce we will highlight key issues in forming partner...experiences. , Minneapoli...rrowhead’s 2010 Personalized Medicine Partn...
(Date:11/5/2009)...ov. 5 DSM Pharmaceutical Products ...lliance with Galenix, Saint Jean D,Illac, France, ...anufacturing partner for Galenix commercial produc...ollaborate on business development opportunities c...sed on the strength of Galenix in drug product dev...
(Date:11/5/2009)... Transgenomic, Inc. (OTC...esults for the quarter ended September 30, 2009. T...e tables that follow. ,, Third Quarter 2009 ,...r $0.01 per share for the third quarter of 2009 as...hare for the third quarter of 2008. ,, Net sal...
(Date:11/5/2009)...mber 5, 2009 Senomyx, In...oprietary taste receptor-based technologies to dis...age, and ingredient supply industries, today provi...lts for the third quarter ended September 30, 2009...r of 2009, compared to $4.0 million for the third ...
Breaking Biology Technology:Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14
...rtners Rockwell Collins and the University of Pa...rraMax, qualified late Wednesday to compete in the... of unmanned vehicles across the Mojave Desert on ... scheduled runs of 2.2- and 2.9-mile qualifying ob...na, Calif. , ,"This is an unprecedented moment fo...
...dside manner is just part of their persona. For ot...edical educator hopes to engender more quickly in ...elopment of the game is the next step in the life ...he UW-Madison Department of Family Medicine whos...vision writing to education. , ,Throughout it all,...
...an article in the Chicago Tribune that Oct. 9 wa... 9, 1940, he would have been 65 years old if he wa...uilding on Dec. 8, 1980. He was 40 years old. The ... the most interesting of the famed Beatles (Im sur...but Im letting the chips fly). , ,We all have our ...
Other Biology Technology:Oshkosh's robotic truck qualifies for DARPA challenge 2Video game technology could improve physician-patient interactions 2Video game technology could improve physician-patient interactions 3Video game technology could improve physician-patient interactions 4Midwest biotech stocks drop like a rock during the third quarter 2Midwest biotech stocks drop like a rock during the third quarter 3
(Date:11/4/2009)...s., Oct. 20 Aware, Inc. ...technology and biometrics software, today reported...ptember 30, 2009. ,, Michael Tzannes, Aware,s...ier today, we announced an agreement to sell our D...new fabless semiconductor company being spun out o...
(Date:11/4/2009)...LL Scientists at the University of North Carolina...ity of California, San Francisco have developed an... target diseases for existing drugs. , The resea...res how similar the structures of all known drugs ... known as ligands -- of disease targets within the...
(Date:11/3/2009)...may be the ultimate loner of the ocean, cruising t...f researchers has discovered that the sharks have ...that over tens of thousands of years the white sha...ed themselves into a population genetically distin...sharks are a large, highly mobile species," said S...
Breaking Biology News(10 mins):Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7Study points to new uses, unexpected side effects of already existing drugs 2Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 2Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 3Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 4Seek Out Credentials Before Choosing a Physician Is Your Cardiologist Board Certified in Cardiovascular Disease 3F 50689 1Seek Out Credentials Before Choosing a Physician Is Your Cardiologist Board Certified in Cardiovascular Disease 3F 50689 2Seek Out Credentials Before Choosing a Physician Is Your Cardiologist Board Certified in Cardiovascular Disease 3F 50689 3Seek Out Credentials Before Choosing a Physician Is Your Cardiologist Board Certified in Cardiovascular Disease 3F 50689 4Ohio Supreme Court Strikes a Blow to Planned Parenthood in Upholding Regulation of Abortion Pill 50687 1Ohio Supreme Court Strikes a Blow to Planned Parenthood in Upholding Regulation of Abortion Pill 50687 2Texas Health Resources Recognized by National Business Group on Health as Leading Employer Promoting Healthy Lifestyles for Employees 50685 1Texas Health Resources Recognized by National Business Group on Health as Leading Employer Promoting Healthy Lifestyles for Employees 50685 2Texas Health Resources Recognized by National Business Group on Health as Leading Employer Promoting Healthy Lifestyles for Employees 50685 3
...thod for manipulating macromolecules has been deve... at Urbana-Champaign. The technique uses double-st...es. , In previous DNA nanotechnology efforts, dup...ruct geometrical objects in three dimensions. Inst...e researchers are using DNA to control the folding...
...ity of an experimental drug known as GW5638 to cha...researchers understand why drugs like tamoxifen an...e effects of estrogen in some tissues and blocking...tle-known drug may play an important role in preve...ests ways to design new drugs with even more speci...
...thod for manipulating macromolecules has been deve... at Urbana-Champaign. The technique uses double-st...es. , In previous DNA nanotechnology efforts, dup...ruct geometrical objects in three dimensions. Inst...e researchers are using DNA to control the folding...
Other Biology News:Health costs soar as 60 million Americans classed as obese 2Tamoxifen-like drug suggests new ways to selectively block estrogen 2Tamoxifen-like drug suggests new ways to selectively block estrogen 3UN successfully tests 'green' pesticide against locusts 2
Mouse Anti-Rat KAPPA / LAMBDA Monoclonal Antibody, Horseradish Peroxidase Conjugated, Clone MARK-1 / MARL-15 from Cell Sciences
Human / Mouse / Rat Chk1 Kinase, active ELISA development Kit, DuoSet, IC (Intracellular) from R&D Systems
Bovine Bovine Serum Albumin, Alexa Fluor 680 conjugated/tagged from Molecular Probes (Invitrogen)
Axl, phospho ELISA development Kit, DuoSet IC Economy Pack from R&D Systems
Biology Products: